Short-course chemotherapy for pulmonary tuberculosis. A 100-day interrupted regimen.
A 100-day interrupted regimen is described which is a useful and efficacious treatment for pulmonary tuberculosis. It is well tolerated, guarantees treatment supervision, and has acceptable relapse rates under normal programme conditions. The 5-day-a-week administration makes it particularly suitable for industrial medical services as well as for other outpatient health care clinical services.
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011718:Pyrazinamide / Q000008:administration & dosage; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage; D013307:Streptomycin / Q000008:administration & dosage; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D004338:Drug Combinations; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin